• HOBt: From Coupling Chemistry to SAR Decisions

  2026-08-13

  HOBt (1-Hydroxybenzotriazole) is more than a peptide-coupling additive: it can connect activation chemistry, stereochemical control, and medicinal-chemistry sample quality. This case study uses a glucagon receptor antagonist synthesis to show how HOBt informs practical route and assay decisions.

• Phalloidin B7678: F-Actin Workflow Guide

  2026-08-13

  Phalloidin (B7678) is a cyclic heptapeptide toxin that binds filamentous actin with high affinity for endpoint cytoskeleton visualization and actin filament stabilization. It is suited to fixed or permeabilized samples and cell-free assays, but not to live-cell imaging or experiments that require reversible actin dynamics.

• NLRP3 Astrocyte Phenotypes in Morphine Tolerance

  2026-08-12

  Yuan et al. identify a connection between NLRP3 inflammasome activation, A1-like astrocyte changes, and the development of morphine tolerance in a mouse spinal-cord model. Pharmacological NLRP3 inhibition with MCC950 slowed tolerance and normalized inflammatory and astrocyte phenotype markers, supporting a neuroimmune mechanism that warrants further cell-specific validation.

• Acifran: A Receptor-Aware Guide to Lipid Signaling

  2026-08-12

  Acifran is a research agonist for HCAR2/GPR109A and HCAR3/GPR109B that connects lipid signaling pathway modulation with receptor-resolved assay design. This article interprets recent cryo-EM findings and translates them into practical choices for lipid metabolism and metabolic disorder research.

• DiscoveryProbe FDA-approved Drug Library for GPCRs

  2026-08-11

  The DiscoveryProbe FDA-approved Drug Library enables mechanism-led GPCR profiling, combining broad pharmacology with practical assay-design guidance. Learn how iterative screening and orthogonal validation can convert phenotypic hits into credible pharmacological probes.

• ω-Agatoxin IVA Suppresses Epileptogenesis

  2026-08-11

  This rat study identifies selective P/Q-type Cav2.1 calcium-channel blockade with ω-agatoxin IVA as a strategy for suppressing chemical kindling, epileptic discharges, and apoptosis-associated changes. By combining seizure behavior, freely moving EEG, motor testing, and regional immunohistochemistry, the work links Cav2.1 activity with both epileptogenesis and neurobiological responses involving BDNF and cleaved caspase-3.

• BQCA Workflows for M1 Receptor Signaling

  2026-08-10

  Benzyl Quinolone Carboxylic Acid (BQCA) enables selective interrogation of M1 muscarinic receptor potentiation, from ACh dose-response assays to BRET-based studies of GRK-dependent signaling bias. This practical guide connects assay design, brain-relevant readouts, compound handling, and troubleshooting for cognitive function modulation and Alzheimer’s disease research.

• Dacarbazine: From DNA Damage to CINV

  2026-08-09

  Dacarbazine is an antineoplastic chemotherapy drug whose clinical value depends on both tumor-cell DNA damage and effective supportive care. This evidence-led guide connects its chemistry, assay interpretation, and chemotherapy-induced nausea and vomiting prevention without repeating conventional workflow reviews.

• HyperPFU™ high-fidelity DNA polymerase Guide

  2026-08-08

  HyperPFU™ high-fidelity DNA polymerase is intended for accurate PCR amplification of long, GC-rich, inhibitor-affected, or otherwise difficult DNA templates. It is appropriate for blunt-ended products used in cloning and sequencing, but not for workflows that require 3′-A overhangs or polymerase-generated sticky ends.

• Ertugliflozin PF-04971729: From Target to Phenotype

  2026-08-07

  Explore how Ertugliflozin (PF-04971729) connects SGLT2 target engagement with renal, cardiovascular, and intestinal research outcomes. This translational framework helps investigators select orthogonal assays and interpret clinical evidence without conflating molecular selectivity with therapeutic ranking.

• HyperScribe All in One mRNA Synthesis Kit Plus 1: Applied In

  2026-08-07

  The HyperScribe All in One mRNA Synthesis Kit Plus 1 streamlines ARCA-capped, immune-evasive mRNA production for RNA vaccine development, RNAi, and functional genomics. Explore experimental workflows, troubleshooting strategies, and practical insights informed by translational research and recent breakthroughs in mRNA vaccine science.

• Danazol: Mechanistic Insights and Strategic Use in Translati

  2026-08-06

  This article delivers a thought-leadership perspective on Danazol (Danocrine), integrating mechanistic detail and workflow strategy for translational researchers. We explore Danazol’s role in androgen receptor signaling, inhibition of steroidogenesis, and endocrine disease modeling—highlighting evidence from recent precocious puberty and prostate cancer studies. The article guides experimental design, protocol optimization, and competitive positioning, emphasizing APExBIO’s high-purity offering to ensure reproducibility and translational value.

• Comparative Cardiovascular Efficacy of SGLT2 Inhibitors in T

  2026-08-06

  This systematic review and network meta-analysis rigorously compares the cardiovascular benefits of individual SGLT2 inhibitors, including Ertugliflozin (PF-04971729), in patients with type 2 diabetes and heart failure. The findings clarify relative efficacy profiles and inform optimal compound selection for both clinical and translational research.

• LC–MS/MS Reveals Oral Prodrug Pathways of GS-441524 In Vivo

  2026-08-05

  This study introduces a validated LC–MS/MS approach to elucidate the metabolic conversion of a novel GS-441524 prodrug (NGP-1) into its active antiviral form, mapping absorption and distribution in vitro and in vivo. The findings support prodrug design for improved oral bioavailability and inform translational strategies for anti-SARS-CoV-2 nucleoside analogs.

• DiscoveryProbe FDA-approved Drug Library: Applied Screening

  2026-08-05

  Unlock robust drug repositioning and target identification with the DiscoveryProbe FDA-approved Drug Library. This collection streamlines high-throughput workflows and empowers advanced screening strategies, as evidenced by recent breakthroughs in dual-mode antiviral assays.

15972 records 1/1065 page Next 12345 下5页 Last page